October 9, 2020
RFA-HL-21-015 - HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)
RFA-HL-21-016 - HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
The National Heart, Lung, and Blood Institute (NHLBI) issued Funding Opportunity Announcements (FOAs) on September 14, 2020: RFA-HL-21-015 HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed) and RFA-HL-21-016 HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed) .
A pre-submission technical assistance webinar is being offered to inform potential applicants about RFA-HL-21-015 and RFA-HL-21-016. This will include a review of the purpose and objectives of the FOA, application and peer review requirements, and budget considerations.
All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar to maximize the use of time. Questions should be sent by email to [email protected] by Tuesday, October 20, 2020.
Session date and time:
Thursday, October 22, 2020 at 4:00 pm EST
Event Password: 1234
Call-in Number (US/Canada): 1-650-479-3208
Meeting Number/Access code:126 213 1268
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e98ecab4b98adaf6e450590e22d22d5e4
Participation in this webinar, although encouraged, is optional and is not required for the submission of applications in response to RFA-HL-21-015 and/or RFA-HL-21-016. The webinar will be recorded. Responses to questions will be posted on a Frequently Asked Questions (FAQs) page on the NHLBI Website soon thereafter; search by the RFA number (RFA-HL-21-015), or use the following links:
Name: Vandana Sachdev, MD
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]